• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.29% Nasdaq Down 3.25%

    More On THR.BR

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    ThromboGenics NV (THR.BR)

    -Brussels
    2.96 Up 0.01(0.24%) Feb 5, 11:35AM EST
    Prev Close:2.96
    Open:2.95
    Bid:2.95 x 18600
    Ask:3.00 x 52700
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:2.95 - 3.05
    52wk Range:2.71 - 8.00
    Volume:22,855
    Avg Vol (3m):50,920
    Market Cap:106.66M
    P/E (ttm):N/A
    EPS (ttm):-1.29
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in EUR.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):8.46
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-11) :N/A
    Quarterly EPS Est (Dec-11) :N/A
    Mean Recommendation*:1.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ThromboGenics NV, an integrated biopharmaceutical company, develops and commercializes ophthalmic and oncology medicines in Belgium and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback